drugset / Trial / NCT04958252
A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
RandomizedCrossoverOpen-labelTreatment
Summary
The main objectives of this trial are to investigate safety and tolerability of BI 1569912 in healthy male Japanese subjects following oral administration of single rising doses and multiple doses. Secondary objective is the exploration of pharmacokinetics (PK) of BI 1569912.
Timeline
- Start
- 2021-08-05
- Primary completion
- 2023-10-30
- Completion
- 2023-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1569912 | Unknown | 2.5 mg | Oral |
| Subject | BI 1569912 | Unknown | 5 mg | Oral |
| Subject | BI 1569912 | Unknown | 10 mg | Oral |
| Subject | BI 1569912 | Unknown | 20 mg | Oral |
Indications
No indication recorded.